<i>Limosilactobacillus reuteri</i> DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial

Richard A. Forsgård, Julia Rode, Karin Lobenius-Palmér, Annalena Kamm, Snehal Patil, Mirriam G. J. Tacken, Marleen A. H. Lentjes, Jakob Axelsson, Gianfranco Grompone, Scott Montgomery, Robert J. Brummer

Open source

DOI: 10.1080/19490976.2023.2229938
Published: 2023-07-04
Container: Gut Microbes
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/19490976.2023.2229938,
  title = {<i>Limosilactobacillus reuteri</i>
            DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial},
  author = {Richard A. Forsgård and Julia Rode and Karin Lobenius-Palmér and Annalena Kamm and Snehal Patil and Mirriam G. J. Tacken and Marleen A. H. Lentjes and Jakob Axelsson and Gianfranco Grompone and Scott Montgomery and Robert J. Brummer},
  year = {2023},
  journal = {Gut Microbes},
  doi = {10.1080/19490976.2023.2229938},
  url = {https://doi.org/10.1080/19490976.2023.2229938}
}

RIS

TY  - JOUR
TI  - <i>Limosilactobacillus reuteri</i>
            DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial
AU  - Richard A. Forsgård
AU  - Julia Rode
AU  - Karin Lobenius-Palmér
AU  - Annalena Kamm
AU  - Snehal Patil
AU  - Mirriam G. J. Tacken
AU  - Marleen A. H. Lentjes
AU  - Jakob Axelsson
AU  - Gianfranco Grompone
AU  - Scott Montgomery
AU  - Robert J. Brummer
PY  - 2023
JO  - Gut Microbes
DO  - 10.1080/19490976.2023.2229938
UR  - https://doi.org/10.1080/19490976.2023.2229938
ER  -

APA

Forsgård, R. A., Rode, J., Lobenius-Palmér, K., Kamm, A., Patil, S., Tacken, M. G. J., Lentjes, M. A. H., Axelsson, J., Grompone, G., Montgomery, S., & Brummer, R. J. (2023). <i>Limosilactobacillus reuteri</i> DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial. Gut Microbes. https://doi.org/10.1080/19490976.2023.2229938

Source records

crossref · retrieved 2026-09-25T23:26:00.565Z